
Pharmacally
Corcept
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Corcept
Clinical TrialsCorcept Drives Survival Gain in ALS Despite Missing Primary EndpointTwo-year results from the Phase 2 DAZALS study show sustained survival benefit with dazucorilant in ALS, including up to 87% reduction in risk of death, while the trial…Fact-Checked
Clinical TrialsCorcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLAPhase 3 ROSELLA results show relacorilant plus nab-paclitaxel improved overall survival and reduced progression risk in platinum-resistant ovarian cancer, with a safety profile comparable to chemotherapy alone.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.